Equine Veterinary Therapeutics Market

The equine veterinary therapeutics market is reported to reach a valuation of USD 1,572.6 million in 2025 to USD 3,047.6 million by 2035. Demand for equine veterinary therapeutics is expected to rise at a CAGR of 6.8% over the forecast period. The anti-inflammatory segment dominates the market with share of 41.3% in 2025, owing to their routine application in post-operative recovery, injury management, and chronic conditions. Inactivated vaccine will dominate the vaccine type segment with a 42.3% market share in 2025, owing to their robust immune response and longer duration of protection.